[
    [
        {
            "time": "2023-10-05",
            "original_text": "康泰生物：公司腺病毒载体新冠疫苗生产车间已完成建设并已有试生产，未进行WHO认证",
            "features": {
                "keywords": [
                    "康泰生物",
                    "腺病毒载体",
                    "新冠疫苗",
                    "生产车间",
                    "试生产",
                    "WHO认证"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物：公司腺病毒载体新冠疫苗生产车间已完成建设并已有试生产，未进行WHO认证",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "康泰生物腺病毒载体新冠疫苗获生产许可 阿斯利康增加授权",
            "features": {
                "keywords": [
                    "康泰生物",
                    "腺病毒载体",
                    "新冠疫苗",
                    "生产许可",
                    "阿斯利康",
                    "授权"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物腺病毒载体新冠疫苗获生产许可 阿斯利康增加授权",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]